| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥592.7B | ¥413.1B | +43.5% |
| Operating Income | ¥61.1B | ¥35.5B | +71.9% |
| Ordinary Income | ¥65.5B | ¥37.9B | +72.9% |
| Net Income | ¥42.1B | ¥24.7B | +70.8% |
| ROE | 10.3% | 6.5% | - |
FY2026 Q3 results: Revenue 592.7B yen (YoY +43.5%), Operating Income 61.1B yen (+71.9%), Ordinary Income 65.5B yen (+72.9%), Net Income 42.1B yen (+70.8%). Strong double-digit growth across all profit lines driven by backlog conversion from large EPC projects and robust machinery sales to shipbuilding sector. Operating margin improved 171bp to 10.3% as SG&A ratio declined 255bp to 10.4% despite gross margin compression of 84bp to 20.7%, demonstrating clear operating leverage. ROE reached 10.3%, driven primarily by asset turnover improvement from 0.62x to 0.84x. Contract liabilities accumulated to 9.83B yen, underpinning near-term revenue visibility. Full-year guidance was revised upward with Operating Income raised from 8.55B yen to 90B yen (+4.5B yen), reflecting improved project margins and GX business progress. Dividend increased from 86 yen to 105 yen per share. Non-recurring impairment loss of 501M yen was recorded during the quarter.
Revenue surged 43.5% to 592.7B yen, primarily driven by backlog conversion from large-scale engineering projects secured in prior periods and strong machinery equipment sales to the shipbuilding sector responding to environmental regulations. The Engineering segment delivered 27% revenue growth through project execution progress, while GX business revenue jumped 317% from prior-year backlog digestion. Machinery segment grew 14% on aftermarket services and oil purification equipment demand. Gross profit increased 36.9% to 122.6B yen, though gross margin compressed 84bp to 20.7% due to project mix shifts and input cost pressures. Operating profit surged 71.9% to 61.1B yen as SG&A expenses grew only 14.9% versus 43.5% revenue growth, reducing SG&A ratio from 12.9% to 10.4%. This 255bp efficiency gain more than offset gross margin pressure, expanding operating margin to 10.3% from 8.6%. Non-operating income contributed 4.4B yen including FX gains of 410M yen (up from 254M yen) and dividend income of 180M yen, lifting Ordinary Income 72.9% to 65.5B yen. Special losses of 501M yen from asset impairments created an 18% gap between Ordinary Income and Net Income, though Net Income still grew 70.8% to 42.1B yen. Excluding the non-recurring impairment, earnings quality remained high with core profitability expanding. The performance pattern is revenue up/profit up with amplified profit growth from operating leverage, partially offset by one-time impairment charges at the net income stage.
Engineering Operations generated revenue of 32.1B yen and Operating Income of 1.6B yen, while Machinery Operations recorded revenue of 14.9B yen and Operating Income of 4.2B yen. Based on cumulative figures, Machinery Operations represents the core business with the highest profit contribution despite smaller revenue scale, achieving an operating margin near 28% versus approximately 5% for Engineering. On a consolidated basis including the GX segment, Engineering delivered 321B yen revenue (+27% YoY) and 1.6B yen Operating Income (+377%), with profit surge driven by margin improvement on completed projects and additional construction work orders. Machinery achieved 149B yen revenue (+14%) and 4.2B yen Operating Income (+30%), with growth propelled by oil purification systems and marine environmental equipment alongside aftermarket parts and services. GX business recorded 122B yen revenue (+317%) and 250M yen Operating Income (versus -40M yen loss prior year), achieving second consecutive quarter of profitability driven by biogas and hydrogen project backlog conversion. The core Machinery segment sustained stable high-margin performance, while Engineering segment drove overall revenue growth and GX business turned profitable, contributing to consolidated margin expansion.
Profitability: ROE 10.3% (PY 6.5%), Operating Margin 10.3% (PY 8.6%), Net Profit Margin 7.1% (PY 6.0%). ROE improvement driven by asset turnover expansion from 0.62x to 0.84x and margin gains, while financial leverage remained stable at 1.73x. Cash Quality: OCF/Net Income data not disclosed in XBRL. Operating CF generation supported by contract liabilities of 9.83B yen and work-in-process inventory of 3.68B yen, indicating healthy project pipeline conversion. Investment: CapEx/D&A ratio not disclosed. Investment securities increased 1.97B yen (+44.3%), indicating portfolio enhancement. Financial Health: Equity Ratio 57.7% (PY 57.8%), Current Ratio 222.8% (PY 217.2%). Interest Coverage Ratio reached 305x with net interest expense of only 200M yen, reflecting minimal financial burden. Working capital of 29.46B yen provides strong liquidity buffer. Net Debt/Capital ratio 2.9% demonstrates conservative leverage profile.
Operating CF and detailed cash flow data are not disclosed in the XBRL dataset. Based on balance sheet changes and earnings quality indicators, cash generation appears adequate. Contract liabilities accumulated to 9.83B yen (up from 8.51B yen), representing advance payments from customers that will convert to revenue, providing positive working capital support. Work-in-process inventory increased 1.21B yen (+49.1%) to 3.68B yen, reflecting ongoing project execution that will materialize into receivables and cash upon completion. Trade receivables stood at 29.93B yen, up from prior levels consistent with revenue growth. The company reduced long-term debt by 500M yen (-29.4%) to 1.2B yen, suggesting debt repayment from internal cash generation. Treasury stock increased 212M yen (-36.6% in negative equity terms), indicating share buyback activity. Non-operating FX gains of 410M yen contributed to Ordinary Income but represent non-cash or timing-related items requiring normalization for core cash flow assessment. Asset impairment of 501M yen was a non-cash charge with no direct cash outflow impact. Overall cash generation appears strong based on working capital dynamics and debt reduction, though formal OCF/FCF metrics warrant monitoring when disclosed.
Ordinary Income of 65.5B yen exceeded Operating Income of 61.1B yen by 4.4B yen, with the gap attributable to non-operating income including FX gains of 410M yen, dividend income of 180M yen, and other financial items. The 410M yen FX gain represents 0.7% of revenue and is non-recurring in nature, subject to exchange rate volatility. Net Income of 42.1B yen fell 35.7% below Ordinary Income due to special losses of 5.01B yen, primarily a 501M yen asset impairment charge. This impairment is a one-time non-cash item reflecting asset revaluation and does not impact core operating earnings quality. Adjusting for the impairment, normalized Net Income would approximate 42.6B yen, closely aligned with Ordinary Income after taxes. The company maintains conservative provisioning with warranty reserves of 944M yen (+32.4%) and construction loss reserves of 182M yen, reflecting prudent cost recognition for future obligations. Accrued expenses and liabilities increased in line with revenue growth, indicating appropriate matching of revenues and costs. While OCF data is unavailable, the accumulation of contract liabilities and controlled receivables growth suggest cash-backed earnings. Core earnings quality remains solid with transparent identification of non-recurring items; investors should normalize for FX volatility and exclude impairment charges when assessing sustainable profitability.
Full-year guidance revised upward on January 30, 2026: Revenue 88.5B yen (previous 88.5B yen, unchanged), Operating Income 9.0B yen (previous 8.55B yen, +450M yen or +5.3%), Ordinary Income 9.1B yen (previous 8.60B yen, +500M yen), Net Income 6.85B yen (previous 6.50B yen, +350M yen). Order intake guidance raised from 69.5B yen to 70.5B yen (+1.0B yen). Dividend per share increased from 86 yen to 105 yen (interim 50 yen, year-end 55 yen revised to year-end 160 yen, per PDF context yielding total 210 yen). Q3 progress rates against revised guidance: Revenue 67.0% (592.7B / 885B), Operating Income 67.9% (61.1B / 90B), Ordinary Income 72.0% (65.5B / 91B), Net Income 61.5% (42.1B / 68.5B). At Q3 standard benchmark of 75%, revenue and operating income are tracking slightly behind at 67-68%, suggesting Q4 weighting of approximately 33% of annual totals, which is feasible given contract liabilities and project completion schedules. Net Income progress of 61.5% reflects the one-time impairment impact in Q3; excluding this, normalized progress would be closer to 65%, still implying a strong Q4 required. The upward revision was driven by improved project margins in Engineering (additional construction work and cost reductions), continued strength in Machinery aftermarket sales, and GX business achieving profitability ahead of initial expectations. Management commentary cites high-certainty pipeline projects offsetting some geopolitical headwinds, supporting confidence in achieving raised targets. Order backlog of 81.0B yen provides substantial revenue base for Q4 and beyond.
Annual dividend revised to 105 yen per share (interim 50 yen paid, year-end 55 yen), representing 35.0% payout ratio based on full-year Net Income guidance of 68.5B yen (EPS 300.76 yen). Note that the interim earnings-based payout ratio appears elevated at 118.4% when calculated against 9-month Net Income of 42.1B yen, but this is not the appropriate denominator; management targets full-year earnings. The company adopted a shareholder return policy with 40% payout ratio guideline and minimum DOE (Dividend on Equity) of 3.5%, indicating commitment to progressive and stable dividends. Treasury stock increased by 212M yen during the period, equivalent to approximately 0.5% of equity, reflecting modest share buyback activity as part of total return strategy. Retained earnings stood at 29.94B yen with ample capacity to support dividends. Operating cash generation and minimal debt burden (interest coverage 305x) underpin dividend sustainability. Total return ratio combining dividends and buybacks for the period is not explicitly disclosed but the combination signals balanced capital allocation prioritizing shareholder value. The dividend increase from 86 yen to 105 yen (+22.1%) significantly exceeds Net Income growth guidance (+33% YoY), indicating management confidence in sustainable earnings power and willingness to enhance shareholder returns from strong cash position.
Near-term: Q4 project completions and order intake execution to meet raised full-year guidance of 90B yen Operating Income and 70.5B yen orders; realization of high-certainty GX segment pipeline (biogas, hydrogen) driving continued profitability; machinery segment momentum from shipbuilding cycle and environmental regulation demand; final dividend of 160 yen per share payment; potential additional share buyback announcements under total return policy.
Long-term: Expansion of GX business as core growth driver targeting 23B yen revenue by FY2027 and majority of sales by 2035, with product commercialization in biogas utilization, hydrogen production, and CO2 capture systems; achievement of Mid-Term Plan "Three Years of Leap" targets of 90B yen revenue, 9%+ operating margin, 12%+ ROE, and PBR above 1.0x by FY2027; growth investment allocation of 8B yen (3B yen R&D, 5B yen M&A) focused on GX capabilities; margin enhancement from operating leverage as fixed cost base is diluted by revenue scale; strengthening of aftermarket and recurring revenue streams in machinery segment; potential M&A to accelerate GX technology and market access; capital efficiency improvement initiatives to sustain ROE expansion toward 12% target.
Industry Position (Reference - Proprietary Analysis) Profitability: ROE 10.3% vs. Industry Median 4.9% (2025-Q3, manufacturing sector, n=65). The company's ROE significantly exceeds the industry median, ranking in the upper quartile (IQR 2.8%-8.2%), reflecting superior capital efficiency driven by asset turnover and margin improvement. Operating Margin 10.3% vs. Industry Median 7.3% (IQR 4.6%-12.0%). Operating margin is above median and within the upper half of the interquartile range, indicating strong cost management and pricing power relative to peers. Net Profit Margin 7.1% vs. Industry Median 5.4% (IQR 3.5%-8.9%). Net margin exceeds median and approaches the upper quartile, demonstrating effective conversion of revenue to bottom-line profit. Financial Health: Equity Ratio 57.7% vs. Industry Median 63.9% (IQR 51.5%-72.3%). Equity ratio is modestly below median but within the interquartile range, reflecting balanced leverage and financial stability. Current Ratio 222.8% vs. Industry Median 2.67x (IQR 2.00x-3.56x). Current liquidity is below the median but remains healthy and within the lower-middle range of peers. Growth: Revenue Growth YoY 43.5% vs. Industry Median 2.8% (IQR -0.9%-7.9%). Revenue growth far exceeds industry median and the entire interquartile range, ranking among the highest in the sector due to large project backlog conversion. ROA 3.3% vs. Industry Median 3.3% (2025-Q3). Return on Assets aligns with median, indicating asset productivity consistent with sector norms. Net Debt / EBITDA not disclosed for the company; Industry Median -1.11 (IQR -3.50 to 1.24) suggests most peers operate with net cash positions. Note: Industry benchmarks are reference information from proprietary analysis of publicly available data (manufacturing sector, n=65 companies, 2025-Q3). Comparison based on trailing fiscal periods. Source: Proprietary data.
Project margin volatility: Gross margin compressed 84bp YoY to 20.7% due to project mix shifts and input cost pressures. Large-scale EPC projects carry long execution cycles with exposure to material price fluctuations, subcontractor cost overruns, and foreign exchange movements. Engineering segment warranty reserves increased 32.4% to 944M yen, signaling heightened cost uncertainty. Sustained margin pressure could erode profitability gains if not offset by volume or SG&A leverage.
GX business execution risk and market uncertainty: GX segment represents strategic growth pillar targeting 23B yen revenue and 650M yen Operating Income in FY2026, with long-term goal of majority revenue contribution by 2035. Current GX operating margin remains low at approximately 2%, and business is nascent with unproven product commercialization in hydrogen production, biogas utilization, and CO2 capture. Market adoption timing, technology validation, and competitive intensity introduce significant uncertainty. Failure to scale GX profitably would undermine mid-term ROE and margin targets.
Geopolitical and trade policy headwinds: Management cited U.S. trade policy changes and geopolitical risks causing delays or revisions in customer capital investment plans, particularly impacting large-scale engineering orders. Q3 order intake declined 25% YoY to 36.6B yen due to absence of mega-projects. Prolonged trade tensions, tariffs, or regional instability could defer order pipeline realization, compressing backlog and future revenue visibility. Concentration in specific geographies or end-markets amplifies vulnerability to policy shifts.
Strong operating leverage driving margin expansion: Operating Income grew 71.9% on 43.5% revenue growth, with operating margin improving 171bp to 10.3% as SG&A ratio declined 255bp. Fixed cost dilution from revenue scale is generating material profitability uplift. Management raised full-year Operating Income guidance by 5.3% to 90B yen, signaling confidence in sustaining margin trajectory. Contract liabilities of 9.83B yen and backlog of 81B yen provide near-term revenue visibility to continue leveraging cost base. Achievement of mid-term 9%+ operating margin target appears on track, with potential upside if gross margin stabilizes and GX segment scales profitably.
Capital efficiency inflection toward mid-term targets: ROE reached 10.3%, driven by asset turnover improvement from 0.62x to 0.84x, placing the company within the upper tier of manufacturing sector peers (industry median 4.9%). Management targets 12%+ ROE by FY2027 under the "Three Years of Leap" plan, requiring further margin and/or turnover gains of approximately 170bp. Conservative leverage (Debt/Capital 2.9%, Interest Coverage 305x) and healthy liquidity (Current Ratio 222.8%) provide flexibility for growth investment (8B yen allocated to R&D and M&A) and enhanced shareholder returns (40% payout ratio, DOE 3.5% floor). PBR improvement toward 1.0x is an explicit management goal, with dividend increases (+22% to 105 yen) and modest buybacks signaling commitment. Sustained earnings growth and ROE expansion could catalyze valuation re-rating.
GX business transition presents binary long-term catalyst: GX segment turned profitable in Q2 and sustained gains in Q3 (250M yen Operating Income vs. -40M yen PY), with revenue surging 317% to 122B yen on backlog conversion. Management envisions GX as the majority revenue contributor by 2035, targeting commercialization of hydrogen, biogas, and CO2 capture technologies aligned with decarbonization demand. Near-term, GX is projected to reach 21.5B yen revenue and 650M yen profit in FY2026, validating early-stage market traction. Success in scaling GX profitably would transform the company's growth profile and strategic positioning; conversely, execution delays or technology/market risks could constrain long-term upside. Order pipeline visibility and margin progression in GX warrant close monitoring as a key determinant of multi-year value creation.
This report was automatically generated by AI integrating XBRL earnings data and PDF presentation materials as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.